Back to search
Scientific Name: Ubrogepant
Brand Name: Ubrelvy
Company Owner: Not Available
Mechanism Of Action The currently accepted theory of migraine pathophysiology considers dysfunction of the central nervous system, in particular the trigeminal ganglion, to be the root cause behind the condition.
Description of the Drug: Ubrogepant is an oral CGRP antagonist used in the acute treatment of migraine with or without aura.
Protein Data Bank: Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB15328